Literature DB >> 28631893

Expanding the allelic disorders linked to TCTN1 to include Varadi syndrome (Orofaciodigital syndrome type VI).

Mohammad M Al-Qattan1, Ranad Shaheen2, Fowzan S Alkuraya2,3,4.   

Abstract

Varadi syndrome is a subtype of orofaciodigital syndrome (OFDS) that combines the typical features of OFDS and the posterior fossa features of Joubert syndrome. The only gene known to be mutated in Varadi syndrome is C5ORF42. In this report, we describe the phenotype of a patient with Varadi syndrome who is homozygous for a previously reported mutation in TCTN1 (NM_001082538.2:c.342-2A>G, p.Gly115Lysfs*8) and suggest that allelic disorders linked to TCTN1 include Varadi syndrome, in addition to Joubert syndrome and Meckel-Gruber syndrome.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Joubert syndrome; TCTN1 gene; Varadi syndrome

Mesh:

Substances:

Year:  2017        PMID: 28631893     DOI: 10.1002/ajmg.a.38336

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  3 in total

1.  Bi-allelic Mutations in FAM149B1 Cause Abnormal Primary Cilium and a Range of Ciliopathy Phenotypes in Humans.

Authors:  Ranad Shaheen; Nan Jiang; Fatema Alzahrani; Nour Ewida; Tarfa Al-Sheddi; Eman Alobeid; Damir Musaev; Valentina Stanley; Mais Hashem; Niema Ibrahim; Firdous Abdulwahab; Abduljabbar Alshenqiti; Fatma Mujgan Sonmez; Nadia Saqati; Hamad Alzaidan; Mohammad M Al-Qattan; Futwan Al-Mohanna; Joseph G Gleeson; Fowzan S Alkuraya
Journal:  Am J Hum Genet       Date:  2019-03-21       Impact factor: 11.025

2.  Function and transcriptional regulation of TCTN1 in oral squamous cell carcinoma.

Authors:  Guangliang Bai; Ning Wei; Fang Li; Peng Zhao; Zhen Meng; Bo Zou; Yujiao Liu; Kai Xu; Keyi Li; Chao Yao; Peng Yang
Journal:  Oncol Rep       Date:  2021-12-03       Impact factor: 3.906

Review 3.  Clinical and genetic heterogeneity of primary ciliopathies (Review).

Authors:  Ina Ofelia Focșa; Magdalena Budișteanu; Mihaela Bălgrădean
Journal:  Int J Mol Med       Date:  2021-07-19       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.